Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pfizer
Pfizer
Page 36 of 37
Health
CVS/Caremark will no longer cover these drugs, including Viagra
By
Chris Matthews
August 7, 2015
Finance
Ireland’s Horizon Pharma launches hostile, $3 billion bid for U.S. rival
By
Tom Huddleston Jr.
July 7, 2015
Commentary
Why America’s patent system is not killing innovation
By
David J. Kappos
May 8, 2015
Features
McDonald’s hikes pay, and Europe targets Apple, Google — 5 things to know today
By
John Kell
April 2, 2015
Finance
Fat Pharma: Pfizer-Hospira and the top 10 overpriced drug deals ever
By
Jen Wieczner
February 6, 2015
Commentary
U.S. corporate tax reform: why Obama’s good ideas don’t add up
By
Robert Pozen
February 5, 2015
Finance
Pfizer to acquire Hospira in a deal worth about $15 billion
By
Fortune Editors
February 5, 2015
Features
In speed mode, FDA approves Pfizer’s big new drug early
By
Jen Wieczner
February 4, 2015
Finance
Zoetis shares spike on reported Ackman stake purchase
By
Tom Huddleston Jr.
November 11, 2014
Features
Facebook earnings and MSG split — 5 things to know today
By
Ben Geier
October 28, 2014
Features
New Targets and new houses (oh, and Ebola) — 5 things to know today
By
Ben Geier
October 24, 2014
Finance
Are U.S. corporate tax inversions a necessary crisis?
By
Robert Litan
July 18, 2014
International
Canada: A penalty box for pharma innovation
By
David J. Kappos
July 2, 2014
Finance
AstraZeneca fails to win FDA panel backing for cancer treatment
By
John Kell
June 26, 2014
Finance
AstraZeneca shareholders upset by “quick” Pfizer rejection
By
Laura Lorenzetti
May 20, 2014
Most Popular
Success
MacKenzie Scott gifts $80 million to Howard University, marking one of the school’s largest donations in its 158-year...
By
Sydney Lake
Success
IBM’s CEO disagrees with JPMorgan CEO Jamie Dimon’s disdain for texting in meetings: ‘Telling people they can't use...
By
Preston Fore
Economy
Trump’s former trade architect says the president can’t backtrack on tariffs because he’s ‘too committed’ now: ‘That...
By
Eva Roytburg